In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones asdetermined by E test

Citation
Kb. Waites et al., In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones asdetermined by E test, ANTIM AG CH, 43(10), 1999, pp. 2571-2573
Citations number
15
Categorie Soggetti
Microbiology
Journal title
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
ISSN journal
00664804 → ACNP
Volume
43
Issue
10
Year of publication
1999
Pages
2571 - 2573
Database
ISI
SICI code
0066-4804(199910)43:10<2571:IVSOMH>2.0.ZU;2-O
Abstract
Twenty isolates of Mycoplasma hominis were tested for their susceptibility to six fluoroquinolones by the E test. The MICs at which 90% of the isolate s were inhibited (in micrograms per milliliter) were as follows: sparfloxac in, 0.031; clinafloxacin, moxifloxacin, and trovafloxacin, 0.063; levofloxa cin, 0.25; and ciprofloxacin, 0.5. Increasing the amount of inoculum or inc ubation in CO2 elevated MICs by less than or similar to 1 dilution. E tests produce fluoroquinolone MICs comparable to those obtained by agar and micr obroth dilution for M. hominis.